株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

合成生物学:世界市場

Synthetic Biology: Global Markets

発行 BCC Research 商品コード 224398
出版日 ページ情報 英文 315 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.91円で換算しております。
Back to Top
合成生物学:世界市場 Synthetic Biology: Global Markets
出版日: 2018年06月26日 ページ情報: 英文 315 Pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

世界の合成生物学市場は、2017年の44億米ドルから、2022年までに139億米ドルまで拡大すると見られています。市場は、2017年〜2022年のCAGR (複合年間成長率) で、26.0%の成長が予測されています。

当レポートでは、世界の合成生物学市場について調査分析し、主要製品、実現技術、対応技術に焦点を当てて、5ヶ年予測、戦略的提携、産業構造、競合情勢、特許、市場促進要因など、体系的な情報を提供しています。

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 概要

  • 合成生物学技術
  • 合成生物学とは
  • 合成生物学の開発段階
  • 合成生物学市場の成長促進要因
  • 世界の合成生物学関連製品市場
  • 製品・技術のライフサイクル状況
  • 合成生物学産業

第4章 市場・技術背景

  • イントロダクション
  • 合成生物学技術の概要
  • イネーブリング技術
  • 生物学的要素・統合システム技術
  • 対応製品

第5章 合成生物学の応用

  • イネーブリング技術の応用
  • 生物学的要素と統合システムの応用
    • 合成遺伝子
    • BioBrickパーツ
    • 統合システム
  • 対応製品の応用
    • 医薬品
    • 産業バイオテクノロジー
    • 農業
    • データストレージ

第6章 合成生物学産業

  • 産業用バイオテクノロジーバリューチェーン
  • 産業構造力
  • 製品・技術のライフサイクル
  • DNAシークエンシング装置産業
  • 第3世代シークエンシング産業
  • DNA合成産業
  • 遺伝子編集産業
  • 合成生物学オーガニズムデザイン・ファウンドリー産業
  • ソフトウェア産業
  • 農業
  • 消費財産業
  • 化粧品/スキンケア産業
  • 飲食品産業
  • 医療産業
  • 工業化学物質
  • セルフリーシステム産業
  • 買収・戦略アライアンス

第7章 合成生物学市場

  • 産業成長促進要因
  • 合成生物学市場:エンドユーザー産業別
  • 合成生物学市場:製品タイプ別
  • 対応製品市場
  • 地域別市場

第8章 特許

  • イントロダクション
  • 基本的特許
  • 合成生物学産業の特許分析
  • ゲノム編集特許

第9章 企業プロファイル

図表

List of Tables

  • Summary Table: Global Synthetic Biology Market, by Product Type, Through 2022
    • Table 1: Report Scope
    • Table 2: Synthetic Biology Paradigm
    • Table 3: Synthetic Biology Market Driving Forces
    • Table 4: Global Synthetic Biology Market, by End-User Industry, Through 2022
    • Table 5: Synthetic Biology Products and Technology Life-Cycle Stage
    • Table 6: Synthetic Biology Industry, by Market Focus
    • Table 7: Synthetic Biology Definitions
    • Table 8: Synthetic Biology History
    • Table 9: Paradigm Shift Caused by Synthetic Biology
    • Table 10: Genetic Engineering and Synthetic Biology Compared
    • Table 11: Synthetic Biology Applications, by Technology
    • Table 12: Importance of Enabling Technologies
    • Table 13: Cost to Sequence a Single Human Genome, 2001-2017
    • Table 14: DNA-Synthesis Costs, 2006 and 2017
    • Table 15: Comparisons of Gene-synthesis Technologies
    • Table 16: Importance of Microfluidics Technologies in Synthetic Biology
    • Table 17: Next-Generation Sequencing Technologies, by Company
    • Table 18: Gene Editing Technologies
    • Table 19: Comparison of Gene Editing Platforms
    • Table 20: Potential Market Applications for Gene-Drive-Modified Organisms
    • Table 21: Synthetic-Biology Bioinformatics Technologies
    • Table 22: Nucleic Acids, Genes and Genomes
    • Table 23: Synthetic DNA
    • Table 24: Synthetic Genes as Molecular-Biology Tool
    • Table 25: Synthetic Genes Versus Traditional PCR Cloning
    • Table 26: DNA Constructs
    • Table 27: Attributes of a Minimal Genome
    • Table 28: Enabled Technologies: Key Application Fields
    • Table 29: Metabolic Engineering for Artemisinic Acid
    • Table 30: Research and Development Applications for Synthetic-Biology Products
    • Table 31: Microbiomes: Synthetic Biology Approaches
    • Table 32: Contribution of Synthetic Biology to Biofuels
    • Table 33: Synthetic Biology Initiatives Relating to the Microbiome
    • Table 34: Synthetic Biology Products Impacted by Enabling Technologies
    • Table 35: Biologic Components and Integrated Systems Near-Term Applications
    • Table 36: Synthetic Genes Near-Term Applications
    • Table 37: E. coli as a Chassis Organism
    • Table 38: Drug Discovery and Development Applications for Synthetic Biology Products
    • Table 39: Gene-Editing Near-term Clinical Applications
    • Table 40: CAR-T Cell Alliances and Synthetic Biology Platforms
    • Table 41: Synthetic Biology Enabled Pharmaceutical Applications
    • Table 42: Industrial Biotechnology Applications
    • Table 43: Synthetic Biology-Enabled Biofuels Applications
    • Table 44: Growth Status of Specialty Versus Drop-in Biofuels, 2000-2020
    • Table 45: Synthetic-Biology-Enabled Agriculture and Animals Applications
    • Table 46: Regulatory Status of Gene-Edited Crops
    • Table 47: Synthetic Biology Industry Structural Forces
    • Table 48: Synthetic Biology Products and Technology Life-Cycle Stage
    • Table 49: Next-Generation Sequencing Instrument Company Summary
    • Table 50: Third-Generation Sequencing Industry
    • Table 51: Synthetic DNA Key Competitor Strategies
    • Table 52: Gene Synthesis Workflow
    • Table 53: Gene Synthesis Market Factors of Differentiation
    • Table 54: Gene Editing Tools Industry
    • Table 55: Agricultural Gene Editing Industry
    • Table 56: Organism Design and Automation Industry
    • Table 57: Market Focus for Selected Synthetic Biology Software Companies
    • Table 58: Agriculture Industry
    • Table 59: Consumer Products Industry
    • Table 60: Cosmetics/Skin Care Industry
    • Table 61: Food and Beverages Industry
    • Table 62: Healthcare Industry
    • Table 63: Microbiome Therapeutics Industry
    • Table 64: Industrial Chemicals Industry
    • Table 65: Leading Companies in the Cell-Free Industry
    • Table 66: Recent Synthetic Biology Industry Acquisitions
    • Table 67: Recent Strategic Alliances
    • Table 68: Synthetic Biology Growth Driving Forces
    • Table 69: Global Synthetic Biology Research Market, by Product Type, Through 2022
    • Table 70: Global Healthcare Market, by Product Type, Through 2022
    • Table 71: Global Industrial Chemicals Market, by Product Type, Through 2022
    • Table 72: Global Agriculture Market, by Product Type, Through 2022
    • Table 73: Global Consumer Market, by Product Type, Through 2022
    • Table 74: Global Food and Beverages Market, by Product Type, Through 2022
    • Table 75: Global Synthetic Biology Market, by Product Type, Through 2022
    • Table 76: Global Enabling Products Market, by Product Type, Through 2022
    • Table 77: Global Enabling Products Market, by End-Use Industry, Through 2022
    • Table 78: Global Biologic Components Market, by Type, Through 2022
    • Table 79: Global Biologic Components Market, by End-User Industry, Through 2022
    • Table 80: Global Integrated Systems Market, by Type, Through 2022
    • Table 81: Global Integrated Systems Market, by End-User Industry, Through 2022
    • Table 82: Biodiesel Fuel Performance Comparison
    • Table 83: Artemisinin Drug Production Comparison
    • Table 84: Sweetener Product Comparison
    • Table 85: Global Enabled Products Market, by Industry, Through 2022
    • Table 86: Global Healthcare Market, by Sector, Through 2022
    • Table 87: Global Consumer Products Market, by Type, Through 2022
    • Table 88: Global Food and Beverages Market, by Type, Through 2022
    • Table 89: Factors for Synthetic Biology-Based Chemical Processes
    • Table 90: Global Industrial Chemicals Market, by Product Type, Through 2022
    • Table 91: Advanced Biofuel Growth Factors
    • Table 92: Crude Oil Prices, 2011-2018
    • Table 93: Strategic Shifts in Biofuels
    • Table 94: Global Biofuels Market, by Fuel Type, Through 2022
    • Table 95: Global Agriculture Market, by End Use, Through 2022
    • Table 96: Global Agriculture Animals Market, by Applications, Through 2022
    • Table 97: Mosquito-Control Methods
    • Table 98: Aedes Aegypti Initial Markets
    • Table 99: Global Crop Enhancements Market, by Crop Type, Through 2022
    • Table 100: Advantages of Gene Editing for Crop Enhancement
    • Table 101: Gene-edited Crops Market Landscape
    • Table 102: Gene-Edited Crops Commercialization Pathway
    • Table 103: Global Synthetic Biology Market, by Region, Through 2022
    • Table 104: Global Enabling Products Market, by Region, Through 2022
    • Table 105: Global Core Products Market, by Region, Through 2022
    • Table 106: Global Enabled Products Market, by Region, Through 2022
    • Table 107: Biofuel Blends Mandates in Key Countries
    • Table 108: Synthetic Biology Patent Scope
    • Table 109: Synthetic Biology Foundational Patents
    • Table 110: Synthetic Biology Patent Landscape, by Company
    • Table 111: Patent Description, by Company
    • Table 112: Gene Editing Tool-Related Patents, by Region, 2007-2017
    • Table 113: Gene Editing Patent Leaders, 2007-2017
    • Table 114: CRISPR-cas9 Intellectual Property Landscape
    • Table 115: Agrivida Technical Approach
    • Table 116: Engineered-Organism Workflow
    • Table 117: Illumina NGS Platforms

List of Figures

  • Summary Figure: Global Synthetic Biology Market, by Product Type, 2016-2022
    • Figure 1: Synthetic Biology Value-Added Chain
    • Figure 2: From the Natural to the Artificial
    • Figure 3: Scale of Synthetic Biology
    • Figure 4: Schematic of DNA Synthesis Technologies
    • Figure 5: Microarrays in DNA Synthesis
    • Figure 6: Role of Promoters and Reporters in Synthetic-Biology Systems
    • Figure 7: How Synthetic Biology Creates Enabled Products
    • Figure 8: Industrial Biotechnology Value Chain with Synthetic Biology Leverage Points
目次
Product Code: BIO066E

Report Highlights

The global market for synthetic biology will grow from nearly $4.4 billion in 2017 to $13.9 billion by 2022, with a compound annual growth rate (CAGR) of 26.0% for the period of 2017-2022.

Report Scope

The scope of this study includes core synthetic biology products (synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-free systems and production systems), enabling technologies (DNA sequencing, DNA synthesis and assembly, gene editing, bioinformatics and specialty media) and enabled technologies (healthcare, industrial chemicals, consumer products, food and beverages, and agriculture) that are already commercialized or are forecast to be commercialized within the next five years.

We analyze key synthetic biology technologies and products to determine present and future market status and forecasted growth from 2017 through 2022. We also discuss strategic alliances, industry structures, competitive dynamics, patents, and market-driving forces.

BCC Research examines the synthetic biology industry by market segment, including the following segments: DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries, software, and the following enabled products sectors: agriculture, consumer products, cosmetics/skin care, food and beverages, healthcare, and industrial chemicals.

The role of key strategic alliances and acquisitions from 2016 through 2017 is discussed. Emerging markets including synthetic genes, synthetic biology-enabled drugs and vaccines, genome-edited crops, and chassis organisms, as well as metabolically engineered factories for producing synthetic fuels and specialty chemicals are analyzed, and more than 185 companies in these fields are highlighted.

Report Includes:

  • An overview of the global markets for synthetic biology
  • Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Coverage of core synthetic biology products: synthetic genes, other DNA parts, chassis organisms, synthetic cells
  • Coverage of enabling technologies: DNA sequencing, oligonucleotides, specialty media, bioinformatics
  • Coverage of enabled technologies: biofuels, specialty chemicals, diagnostics, pharmaceuticals, agriculture
  • Analysis of the synthetic biology industry structure, competitors, and intellectual property landscape
  • Assessments of the products and technologies most commercially viable now and in the near future
  • Company profiles of major players in the market, including Illumina, Inc, New England Biolabs, Precision Biosciences, Royal Dsm Nv, Sgi-Dna Inc., Synthetic and Genomics, Inc

Table of Contents

Chapter 1 - Introduction

  • Study Goals and Objectives
  • Reasons for Doing the Study
  • Contribution of the Study and for Whom
  • Scope and Format
  • Methodology
  • Information Sources
  • Geographical Breakdown
  • Analyst's Credentials
  • Related BCC Research Reports

Chapter 2 - Summary and Highlights

Chapter 3 - Overview

  • Synthetic Biology Technologies Covered in this Report
  • What is Synthetic Biology?
  • Development Stage of Synthetic Biology
  • Forces Driving Growth in the Synthetic Biology Market
  • Global Markets for Synthetic Biology Products
  • Life-Cycle Status of Products and Technologies
  • The Synthetic Biology Industry

Chapter 4 - Market and Technology Background

  • Introduction
    • Synthetic Biology Defined
    • History of Synthetic Biology
    • Paradigm Shift in Biology
  • Synthetic Biology Technology Overview
  • Enabling Technologies
    • DNA-Synthesis and DNA-Sequencing Cost Trends
    • DNA Synthesis Technologies
    • Microfluidic Technologies
    • Next-Generation Sequencing Technologies
    • Gene Editing
    • Gene Drives
    • Bioinformatics Technologies
  • Biologic Components and Integrated Systems Technologies
    • Synthetic DNA
    • BioBrick Parts
    • Minimal Genomes and Chassis Organisms
  • Enabled Products
    • Pathway Engineering
    • Research and Development Applications
    • Synthetic Biology and the Microbiome
    • Synthetic Biology in Biofuels Feedstocks
    • Synthetic Biology Initiatives

Chapter 5 - Synthetic Biology Applications

  • Enabling Technologies Applications
  • Biologic Components and Integrated Systems Applications
    • Synthetic Genes
    • BioBrick Parts
    • Integrated Systems
  • Enabled Products Applications
    • Pharmaceuticals
    • Industrial Biotechnology Applications
    • Agricultural Applications
    • Data Storage Applications

Chapter 6 - Synthetic Biology Industry

  • Industrial Biotechnology Value Chain
  • Industry Structural Forces
  • Products and Technology Life Cycle
  • DNA Sequencing Industry
  • Third-Generation DNA Sequencing Industry
  • DNA Synthesis Industry
    • Gene Synthesis Workflow
    • Gene Synthesis Value Chain
    • Synthetic Gene Market Segments
  • Gene Editing Industry
  • Synthetic-Biology Organism Design and Foundries Industry
  • Software Industry
  • Agriculture Industry
  • Consumer Products Industry
  • Cosmetics/Skin Care Industry
  • Food and Beverages Industry
  • Healthcare Industry
  • Industrial Chemicals Industry
  • Cell-Free Systems Industry
  • Acquisitions and Strategic Alliances

Chapter 7 - Synthetic Biology Markets

  • Driving Forces for Industry Growth
  • Synthetic Biology Markets by End-User Industry
    • Research Market
    • Healthcare Market
    • Industrial Chemicals Market
    • Agriculture Market
    • Consumer Market
    • Food and Beverages Market
  • Synthetic Biology Markets by Product Type
    • Enabling Products Market
    • Biologic Components Market
    • Integrated Systems Market
  • Enabled Products Markets
    • Sources of Competitive Advantage
    • Healthcare Market
    • Consumer Products Market
    • Food and Beverages Market
    • Chemicals Market
    • Agriculture Market
  • Geographic Markets
    • Synthetic Biology Products by Region
    • Enabling Products Market by Region
    • Core Products Market by Region
    • Enabled Products Market by Region

Chapter 8 - Patents

  • Introduction
  • Foundational Patents
  • Synthetic Biology Industry Patent Analysis
  • Gene Editing Patents

Chapter 9 - Synthetic Biology Company Profiles

  • 20N LABS INC.
  • ABEONA THERAPEUTICS INC.
  • ACTIVE MOTIF
  • AEMETIS INC.
  • AGENOVIR
  • AGERIA
  • AGILENT TECHNOLOGIES INC.
  • AGILIS BIOTHERAPEUTICS LLC
  • AGRIMETIS LLC
  • AGRIVIDA
  • ALGENUITY
  • AMBRX INC.
  • AMYRIS INC.
  • ANTHEIA INC.
  • ARAKNITEK
  • ARANEX BIOTECH
  • ARDRA BIO INC.
  • ARZEDA CORP.
  • ASTRAZENECA PLC
  • ATG BIOSYNTHETICS GMBH
  • ATUM
  • AVA FOOD LABS INC.
  • AVIDBIOTICS CORP.
  • AZARGEN BIOTECHNOLOGIES PTY LTD.
  • AZITRA INC.
  • BASF AG
  • BAYER AG
  • BELL BIOSYSTEMS
  • BENCHLING
  • BETA RENEWABLES
  • BIOAMBER INC.
  • BIO BASIC INC.
  • BIOCAPITAL HOLDINGS LLC.
  • BIOCELLECTION INC.
  • BIOMAX INFORMATICS AG
  • BIOMX LTD.
  • BIONEER CORP.
  • BIO S&T INC.
  • BIOSYNTIA APS
  • BLUEBIRD BIO INC.
  • BLUE HERON BIOTECH LLC
  • BLUE MARBLE BIOMATERIALS
  • BOLT THREADS
  • BRISTOL-MYERS SQUIBB COMPANY
  • CALYSTA INC.
  • CALYXT INC.
  • CARGILL, INC.
  • CARIBOU BIOSCIENCES INC.
  • CASZYME
  • CATALOG TECHNOLOGIES INC.
  • CELL DESIGN LABS
  • CELLECTIS SA
  • CELL FREE TECHNOLOGY LTD.
  • CHAIN BIOTECHNOLOGY LTD
  • CIBUS INC.
  • CLARA FOODS CO.
  • C-LECTA GMHB
  • CODAGENIX INC.
  • CODEXIS, INC.
  • CORBION BIOTECH INC.
  • DEMURIS LTD.
  • DESKTOP GENETICS LTD.
  • DNA SCRIPT
  • DOWDUPONT, INC.
  • EDITAS MEDICINE INC.
  • EGENESIS INC.
  • ELIGO BIOSCIENCE
  • ENBIOTIX INC.
  • ENEVOLV INC.
  • EPIBIOME INC.
  • EPOCH LIFE SCIENCE INC.
  • EUROFINS MWG OPERON
  • EVONETIX
  • EVOLVA SA
  • EXONICS THERAPEUTICS INC.
  • EXXONMOBIL CORP.
  • GEA ENZYMES
  • GELTOR INC.
  • GENEDESIGN, INC.
  • GENEMED SYNTHESIS, INC.
  • GENE ORACLE INC.
  • GENERAY BIOTECH CO. LTD.
  • GENOMATICA
  • GENSCRIPT
  • GEVO, INC.
  • GINKGO BIOWORKS
  • GLAXOSMITHKLINE PLC
  • GLOBAL BIOENERGIES
  • GLOWEE
  • GLYCOSBIO FOOD SCIENCES
  • GOODYEAR TIRE & RUBBER CO.
  • GREEN BIOLOGICS LTD.
  • HELIXWORKS TECHNOLOGIES LTD.
  • HOMOLOGY MEDICINES
  • HORIZON DISCOVERY GROUP PLC
  • HUVEPHARMA
  • ILLUMINA, INC.
  • IMPOSSIBLE FOODS INC.
  • INDUSTRIAL MICROBES INC.
  • INGENZA LTD.
  • INOVIO PHARMACEUTICALS INC.
  • INTEGRATED DNA TECHNOLOGIES INC.
  • INTELLIA THERAPEUTICS
  • INTERNATIONAL BUSINESS MACHINES
  • INTREXON CORP.
  • JUNO THERAPEUTICS INC.
  • KANEKA CORP.
  • LABGENIUS LTD.
  • LANZATECH
  • LATTICE AUTOMATION INC.
  • LC SCIENCES
  • LOCUS BIOSCIENCES
  • LUMEN BIOSCIENCE
  • LYGOS INC.
  • MERCK & CO.
  • METAMIXIS
  • MICHELIN SA
  • MICROBYRE
  • MICROSOFT CORP.
  • MILIS BIO LTD.
  • MIRACULEX
  • MODERN MEADOW
  • MODULAR GENETICS INC.
  • MOLECULAR ASSEMBLIES INC.
  • MORPHOSYS AG
  • MUSE BIOTECHNOLOGY INC.
  • MYRIANT CORP.
  • NEW ENGLAND BIOLABS
  • NOVARTIS PHARMA AG
  • NOVOME BIOTECHNOLOGIES INC.
  • NOVOZYMES A/S
  • NOVVI LLC
  • NUCELIS LLC
  • NUCLERA NUCLEICS LTD.
  • OMEGA BIO-TEK INC.
  • ORAGENICS INC.
  • OXFORD GENETICS LTD.
  • PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
  • PERFECT DAY INC.
  • PFIZER, INC.
  • PHYLOGICA LTD.
  • PHYTOWELT GREEN TECHNOLOGIES GMBH
  • PIVOT BIO
  • POSEIDA THERAPEUTICS INC.
  • PRECISION BIOSCIENCES
  • PROKARIUM HOLDINGS LTD.
  • QTEROS INC.
  • RADIANT GENOMICS INC.
  • RENNOVIA INC.
  • REVERDIA
  • ROYAL DSM NV
  • SAMPLE6 TECHNOLOGIES
  • SANGAMO THERAPEUTICS INC.
  • SCARAB GENOMICS LLC
  • SGI-DNA INC.
  • Shanghai SHINEGENE MOLECULAR BIO-TECHNOLOGIES INC.
  • SIGMA ALDRICH CORP.
  • SILICOLIFE LDA.
  • SOLIGENIX INC.
  • SPIBER INC.
  • STRING BIO
  • SUGARLOGIX
  • SYNBIOTA
  • SYNBIO TECHNOLOGIES CO., LTD.
  • SYNLOGIC
  • SYNPROMICS LTD.
  • SYNTHACE LTD.
  • SYNTHEGO CORP.
  • SYNTHETIC BIOLOGICS INC.
  • SYNTHETIC GENOMICS, INC.
  • SYNTHORX INC.
  • SYNVITROBIO INC.
  • TAXA BIO-ENGINEERING
  • TEEWINOT LIFE SCIENCES CORP.
  • TEPHA, INC.
  • TESELAGEN BIOTECHNOLOGY INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • TRANSCRIPTIC, INC.
  • TRITON ALGAE INNOVATIONS LTD.
  • TWIST BIOSCIENCE
  • TYSON FOODS INC.
  • UBA BIOLOGIX
  • VEDANTA BIOSCIENCES
  • VERDEZYNE INC.
  • XYCROBE THERAPEUTICS INC.
  • YIELD10 BIOSCIENCES
  • ZIOPHARM ONCOLOGY INC.
  • ZYMERGEN
  • ZYMOCHEM INC.
Back to Top